Orthofix International (OFIX) Misses Q4 EPS by 61c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as higher yields and oil prices flag inflation risk
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
- Oracle and these 6 stocks are newest addition to Mizuho Top Picks list
BTIG Reiterates Neutral Rating on Orthofix International (OFIX)
February 25, 2025 1:01 PM ESTBTIG analyst Ryan Zimmerman reiterated a Neutral rating on Orthofix International (NASDAQ: OFIX).
The analyst comments "We maintain our Neutral following 4Q24 results. OFIX reported rev. of $215.7M (7.6% Y/Y, 7.8% xFx) above Cons. at $212.7M while adj. EBITDA of $23.9M beat Street ests. of $22.6M. Growth was driven by Global Orthopedics (18.1% Y/Y xFx) and BGT (8.6% Y/Y).... More



